Fibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography
Background. Patients with diabetes mellitus (DM) exhibit increased risk of recurrent myocardial infarction. Maximal clot strength measured by thrombelastography (TEG) is a risk factor for recurrent ischemic events. We hypothesized that diabetic subjects exhibit increased fibrin clot strength in plat...
Saved in:
Main Authors: | Benjamin T. Maatman, Glen Schmeisser, Rolf P. Kreutz |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-01-01
|
Series: | Journal of Diabetes Research |
Online Access: | http://dx.doi.org/10.1155/2018/4543065 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Role of Thrombelastography in Multiple Trauma
by: Victor Jeger, et al.
Published: (2011-01-01) -
Group a Streptococcus remains viable inside fibrin clots and gains access to human plasminogen for subsequent fibrinolysis and dissemination
by: Henry M. Vu, et al.
Published: (2025-02-01) -
Retracted: Changes in Thrombelastography in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease and the Relationship with Lung Function
by: Emergency Medicine International
Published: (2024-01-01) -
The association of muscle weakness with functional disability in older patients with Diabetes mellitus: Measured by three different grip strength thresholds.
by: Sibel Çavdar, et al.
Published: (2025-01-01) -
Measuring Activated Clotting Time during Cardiac Catheterization and PCI: The Effect of the Sampling Site
by: J. C Heemelaar, et al.
Published: (2021-01-01)